Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Swedish trials on nitric oxide technology show promise for hygiene control

NOLabs : 30 November, 2007  (New Product)
NOLabs, the Swedish company developing innovative nitric oxide-containing medical devices based on the NitroSense Technology, has achieved important milestone in the development of a new range of products for wounds infected by MRSA-bacteria.
In experiments performed at the Malmoe University Hospital in Sweden, researchers showed that NOLabs' technology has a promising ability to kill a wide range of pathogens, including MRSA.

According to the US Centers for Disease Control and Prevention 126,000 hospitalisations are related to MRSA and 19,000 deaths are associated with serious MRSA infections every year in US hospitals. Patients at risk for infection with MRSA include those with severe disease, recent surgery or indwelling medical devices, such as urinary catheters.

Goran Beijer, CEO of NOLabs says: 'The recent results show that we are on the right track towards products with an enormous potential globally. The anti-microbial effect of NO will be key in several products that will prevent and/or treat infection depending on dosing. We are now accelerating our development program and expect to have the first products on the market during 2008.'

NOLabs' NitroSense Technology assures controlled, local delivery of pure nitric oxide in a well-defined concentration range during a well-defined time period. The main areas are prevention of Catheter related urinary tract infections, relief of neuropathic pain and wound care products with an anti-bacterial effect.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo